Transplantation Research is now indexed in PubMed and PubMed Central. This complies with the open access policies of many funders, including those of the Howard Hughes Medical Institute, NIH, and Wellcome Trust.

Edward K. Geissler

Ed Geissler is a basic scientist in Transplantation at the University Hospital Regensburg working in three primary fields of interest: immunology, solid organ transplantation and immunosuppressive therapies. His focus is on the understanding and prevention of immunologic rejection of transplanted organs and on immunosuppressive therapies that are used to prevent transplant rejection, especially the side effects of these drugs. He is particularly interested in post-transplant development of cancer, and has made a strong translational research effort through molecular targeting to reduce the threat of posttransplant malignancy. In another effort to reduce the burden immunosuppressive drugs, he is leading an initiative to introduce cellular therapy in transplant recipients.

Professor Edward K. Geissler
University of Regensburg, Germany

Alan Jardine

Alan Jardine is a Clinical Professor of Renal Medicine at the University of Glasgow and Honorary Consultant in Medicine & Nephrology at the Western Infirmary in Glasgow. His research interests are in the cardiovascular and other long-term complications of renal disease and transplantation, and their pathophysiological determinants. He leads the Renal Research Group at the University of Glasgow, with ongoing research ranging from laboratory based studies on cardiac and vascular function, to international, multicentre trials. His involvement in the leadership of clinical trials includes some of the first large scale studies to investigate cardiovascular outcomes in this patient group, as well as studies on immunosuppression and anti-viral agents.

Professor Alan Jardine
University of Glasgow, UK